Your Premier Destination for High-Quality Aesthetic Products and Transformative Beauty Solutions
What Is Vitaran? How Korean PN Skin Boosters Work — Mechanism, Ingredients, and Protocol for Clinics
Last updated: June 2026 · Reading time: 8 min
In This Guide
Quick Answer
Vitaran (HP Cell VITARAN) is a polynucleotide (PN) injectable skin booster manufactured by BR PHARM CO., Ltd. (Wonju, Gangwon Province, South Korea). It contains PN 2% (20 mg/mL) extracted from salmon trout raised on BR Pharm’s own managed farms, using the company’s patented purification technology. The product comes in 2 mL × 2 prefilled syringes per box with 33G sterile needles included. Vitaran holds CE, KFDA, and MOCRA (US) certifications and was developed with a specific focus on reducing injection pain through ionized PN formulation — a clinical advantage that sets it apart from earlier-generation PN injectables.
Why Clinics Choose Vitaran
The Korean PN skin booster market now includes multiple competing products, so why has Vitaran gained rapid adoption in clinics across Korea and internationally? Several factors stand out for practitioners making purchasing decisions:
Vertically integrated raw material supply. BR Pharm is unique among PN manufacturers in that the company manages its own salmon trout farms on the south coast of Korea. This gives them end-to-end control from fish husbandry through DNA extraction, purification, and final product formulation — all done in-house using their patented technology. The raw material PDRN is DMF (Drug Master File) registered with MFDS (Korea’s FDA equivalent), providing a level of raw material traceability that few competitors can match.
Reduced injection pain. Pain during injection is one of the most common patient complaints with PN treatments. Vitaran addresses this through an ionized PN formulation with optimized osmolarity and pH closer to natural skin. A 12-week clinical study conducted at Wonju Severance Christian Hospital (led by Professor Kim Ji-ae, Department of Plastic Surgery) demonstrated measurably reduced pain during injection, and the results were published in an SCIE-indexed international journal. For practitioners, lower pain means higher patient compliance and rebooking rates.
Triple international certification. Vitaran holds CE certification (No. 2265) for Europe, KFDA approval for Korea, and MOCRA registration (No. 53-955125-811451) for the United States. This three-market regulatory coverage makes it one of the most broadly certified PN injectables available — a significant consideration for clinics serving international patients or operating across regulatory jurisdictions.
LG Chem distribution partnership. In Korea, Vitaran is distributed through LG Chem — one of the country’s largest life science companies. This partnership provides supply chain stability and institutional credibility that smaller PN products cannot offer. For international wholesale sourcing, direct supply from BR Pharm through authorized distributors ensures product authenticity.
How PN Works in Vitaran
Polynucleotides (PN) are long-chain DNA fragments extracted from fish — in Vitaran’s case, from salmon trout (Oncorhynchus mykiss) raised in controlled environments. PN is approximately 95% similar to human DNA at the base level, which gives it high biocompatibility and low immunogenicity when injected intradermally.
Dual Regenerative Pathway
PN operates through the same two pathways as PDRN, but with an important structural difference: PN has a longer molecular chain (higher molecular weight) than PDRN, which gives it both receptor-mediated signaling AND viscoelastic matrix support. Specifically, PN binds to A2A purinergic adenosine receptors on fibroblasts, triggering growth factor secretion and collagen synthesis. Simultaneously, PN provides nucleotide building blocks for DNA repair through the nucleotide salvage pathway. And unlike lower-molecular-weight PDRN, PN’s longer chains create a gel-like scaffold in the dermis that supports tissue architecture — functioning as both a bioactive signal and a structural support.
What Makes Vitaran’s PN Different
Not all PN injectables are created equal. BR Pharm’s patented extraction process produces PN with specific molecular weight characteristics optimized for two goals: maximal biological activity and minimal injection discomfort. The ionized formulation adjusts the pH and osmolarity to closely match human skin, which reduces the stinging sensation that patients often report with PN injections. This isn’t just marketing — it’s backed by the company’s SCIE-published clinical data showing reduced pain scores versus controls.
PN vs PDRN vs Exosomes: Where Vitaran Fits
Understanding the three main Korean regenerative skin booster technologies helps practitioners position Vitaran correctly:
- PN (Vitaran, Rejuran): Higher-molecular-weight DNA fragments that provide both A2A receptor signaling AND structural matrix scaffolding. Injectable. Targets tissue restructuring, scar revision, and overall skin quality.
- PDRN (Curenex Glow, Recell): Lower-molecular-weight DNA fragments focused on A2A receptor activation. More targeted anti-inflammatory and wound-healing effects, less structural support.
- Exosomes (ASCE+ SRLV): Extracellular vesicles carrying miRNAs and proteins for intercellular communication. Fundamentally different delivery mechanism — cell-to-cell signaling rather than receptor binding.
Vitaran sits firmly in the PN category alongside Rejuran but differentiates on pain reduction, manufacturing control, and regulatory breadth.
Full Composition & Specifications
| Parameter | Specification |
|---|---|
| Product Name | HP Cell VITARAN Skin Healer I |
| Active Ingredient | Polynucleotide Sodium (PN) 2.0% — 20 mg/mL |
| Total PN per Box | 40 mg (2 × 20 mg) |
| Source | Salmon trout — BR Pharm’s own managed farms (south coast, Korea) |
| Packaging | 2 mL × 2 prefilled syringes per box |
| Needle | Sterile disposable 33G needles included |
| Formulation | Ionized PN — optimized osmolarity and pH for reduced injection pain |
| Storage | 1–30°C, protected from light |
| Shelf Life | 24 months from manufacturing date |
| Manufacturer | BR PHARM CO., Ltd., Wonju, Gangwon Province, South Korea |
| Certifications | CE 2265, KFDA, MOCRA (US: 53-955125-811451), GMP, ISO 13485 |
| Korea Distribution | LG Chem (since September 2023) |
Vitaran vs Rejuran: Key Differences for Practitioners
Both Vitaran and Rejuran are Korean PN injectables that target skin regeneration through polynucleotide technology. They share the same biological mechanism — A2A receptor activation + nucleotide salvage — but differ in several practical dimensions:
| Factor | Vitaran (BR Pharm) | Rejuran (PharmaResearch) |
|---|---|---|
| PN Concentration | 2% (20 mg/mL) | Varies by variant (Healer, HB, S, I) |
| Pain Profile | Ionized formulation — clinically shown to reduce injection pain | Standard PN gel — some patients report stinging |
| Raw Material Source | BR Pharm’s own salmon trout farms (vertically integrated) | Wild salmon (Oncorhynchus keta) — DOT™ technology |
| US Registration | MOCRA registered | Not MOCRA registered (as of 2026) |
| Product Range | Skin Healer I, II, III + joint injection (J) + topical boosters | Healer, HB, S, I, Tone-Up, Black Healer |
| Korea Distribution | LG Chem | Direct / distributors |
The practical takeaway: Vitaran is often preferred for patients who are sensitive to injection pain or who had a previous negative experience with PN treatments. Rejuran has a longer market track record and a wider product range with specialized variants for different treatment zones. Many clinics stock both and select based on the patient’s pain tolerance and treatment goals.
Recommended Treatment Protocol
Vitaran is administered via intradermal injection using the provided 33G sterile needles. The product is a prefilled syringe — no reconstitution or mixing required.
Injection Technique
Standard delivery is via serial micro-injection (nappage technique) into the superficial to mid-dermis. One syringe (2 mL) covers a full face; the second syringe can be used for the neck, décolletage, or saved for a follow-up treatment. The 33G gauge needle ensures minimal puncture trauma while delivering PN precisely to the target depth.
Session Cadence
A typical protocol involves 3 sessions spaced 2–4 weeks apart as an initial course. Clinical data from the Wonju Severance study evaluated outcomes at 12 weeks. Results duration is approximately 6 months, after which maintenance sessions every 3–6 months help sustain skin quality improvements. For clinics that also use Hyaron for HA hydration, the two products can be alternated in a staggered schedule — Vitaran for regeneration, Hyaron for hydration — maximizing per-patient visit revenue.
Patient Suitability Matrix
| Patient Concern | Vitaran Fit | Clinical Notes |
|---|---|---|
| Fine lines & skin texture | ★★★★★ | Primary indication — collagen stimulation via PN pathway |
| Pain-sensitive patients | ★★★★★ | Key differentiator — ionized PN reduces injection discomfort |
| Dull skin / loss of radiance | ★★★★★ | PN strengthens skin barrier → improved hydration retention → natural glow |
| Redness & inflammation | ★★★★☆ | Anti-inflammatory pathway; BR Pharm has published PN research for atopic dermatitis |
| Acne scars | ★★★★☆ | PN matrix supports scar remodeling; best combined with fractional laser or RF microneedling |
| Pore refinement | ★★★★☆ | Dermal thickening effect improves pore appearance over 3+ sessions |
| Deep volume loss | ★☆☆☆☆ | Not a filler — pair with crosslinked HA fillers for volume |
Recovery Timeline
| Timeframe | Expected Response |
|---|---|
| 0–24 hours | Small injection papules at treatment points. Mild redness. Vitaran’s ionized formulation typically produces less immediate stinging than standard PN injectables. |
| 2–5 days | Papules and redness resolve. Skin begins to feel smoother as PN integrates into the dermal matrix. |
| 2–4 weeks | Collagen synthesis ramps up. Early texture and radiance improvement visible. |
| 6–12 weeks (full protocol) | After 3 sessions: peak results. Improved elasticity, reduced fine lines, strengthened skin barrier. |
| 3–6 months | Results duration. Maintenance sessions every 3–6 months to sustain outcomes. |
Downtime: Minimal. Small papules at injection sites typically resolve within 24–48 hours. PN is 95% similar to human DNA and is biocompatible with low immunogenicity.
Frequently Asked Questions
Who manufactures Vitaran?
BR PHARM CO., Ltd. — a bio-pharmaceutical company headquartered in Wonju, Gangwon Province, South Korea. BR Pharm specializes in PDRN/PN technology and manages its own salmon trout farms for raw material supply. The company holds GMP, ISO 13485, and multiple international certifications. CEO Kim Seok-soon received a Presidential Commendation for contributions to regenerative medicine.
Is Vitaran the same as Rejuran?
No. While both are Korean PN injectables using salmon-derived polynucleotides, they come from different manufacturers with different formulations. Vitaran (by BR Pharm) uses an ionized PN formulation designed to reduce injection pain and is manufactured from company-farmed salmon trout. Rejuran (by PharmaResearch) uses wild salmon DNA with their proprietary DOT™ technology. The biological mechanism is the same — A2A receptor activation and collagen stimulation — but the patient experience during injection and the regulatory status differ.
Does Vitaran hurt less than other PN injections?
According to BR Pharm’s published clinical data (SCIE-indexed journal), the ionized PN formulation in Vitaran produces measurably lower pain scores compared to controls. The optimized osmolarity and pH, closer to natural skin values, reduce the stinging sensation commonly associated with PN injections. Individual experiences vary, but this is one of Vitaran’s key marketed advantages.
Can Vitaran be combined with other treatments?
Yes. Vitaran pairs well with Hyaron for HA hydration, PDRN-based boosters like Curenex Glow for dual-pathway regeneration, and laser or RF microneedling procedures. The two can be alternated or stacked within a treatment plan based on patient goals.
Where can clinics purchase Vitaran wholesale?
Vitaran is available through authorized Korean aesthetic product distributors that source from BR Pharm. The product is shipped with 33G needles included, and the 2-syringe box format supports flexible treatment planning — one syringe per session or both in a single full-face + neck session.
Related Guides for Practitioners
- Korean Skin Boosters: The Complete Guide — Pillar overview of all skin booster technologies
- What Is Rejuran? — The original Korean PN skin booster
- What Is Curenex Glow? — PDRN + multi-peptide skin booster
- What Is Hyaron? — Non-crosslinked HA skin booster
- 5 Common Uses of Laennec Injection — Placental extract therapy guide
Recommended Products
